Merrion Pharmaceuticals Plc : Appointment of Director

23 December 2013

Appointment of Director

Merrion Pharmaceuticals plc, ("Merrion" or the "Company") today announced the appointment of Dr. John Fox (59) as Chief Executive Officer and as a director of Merrion.

In accordance with paragraph (g) of Schedule 2 of the ESM Rules, Dr. Fox has the following disclosures to make.

The following are the directorships and partnerships held by Dr. Fox within the past five years:

Current Directorship(s):
JCMA Research Limited
Ramalex Limited

Past Directorship(s):
Endocrine Pharmaceuticals Ltd (UK
Southampton Asset Management Ltd (UK).

There are no further details that are required to be disclosed under (iii) to (viii) of paragraph (g) of Schedule 2 of the ESM Rules.

 Investor Enquiries:

Investor Enquiries: Merrion Pharmaceuticals Plc. John Fox T [phone] www.merrionpharma.com	Media Enquiries: Slattery Communications Conor Dempsey T [phone] E-mail: [e-mail]
Davy Corporate Finance Ivan Murphy/David Nangle T [phone]